Evidence map›Paper›PMID 28966055›Full record

ArticleCell host & microbe2017

A Subset of Polysaccharide Capsules in the Human Symbiont Bacteroides thetaiotaomicron Promote Increased Competitive Fitness in the Mouse Gut.

Nathan T Porter, Pablo Canales, Daniel A Peterson, Eric C Martens

Open access · bronzeAbstract read
In one paragraph

Article in Cell host & microbe, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 73 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

73 citing papers in PubMed, 1 synthesis or guideline pooled it, 120 citations in OpenAlex.

  1. Pooled it
  2. High-throughput analyses ofGut microbes · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. A system for transferring large genetic loci inApplied and environmental microbiology · 2026
    Article
  10. Article
  11. Article
  12. We need to talk about the virome.Microbiome research reports · 2026
    Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Nathan T PorterDepartment of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
Pablo CanalesDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Daniel A PetersonDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Eric C MartensDepartment of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, MI 48109, USA. Electronic address: emartens@umich.edu.
Johns Hopkins University · USUniversity of Michigan · US

Funding

University of Michigan Center for Gastrointestinal ResearchP30DK034933 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI OWYANG, CHUNG · 1986 to 2021
$22.5M
Cellular Biotechnology Training Program (CBTP)T32GM008353 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SCHWENDEMAN, ANNA · 1991 to 2021
$9.3M
Cellular Biotechnology Training Program (CBTP) - Years 31-35T32GM145304 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Guizhi Zhu · 2022 to 2026
$2.6M
How glycans shape gut microbiota function and assemblyR01GM099513 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MARTENS, ERIC C · 2013 to 2016
$1.2M
Defining a nutrient niche competed for by gut commensal bacteria and pathogensR21AI128120 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MARTENS, ERIC C · 2017 to 2018
$417k
The role of polysaccharide surface capsules in Bacteroides glycan degradationR03DK096023 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MARTENS, ERIC C · 2012 to 2013
$150k
NIAID NIH HHS R21 AI128120NIDDK NIH HHS P30 DK034933NIDDK NIH HHS R03 DK096023NIGMS NIH HHS R01 GM099513NIGMS NIH HHS T32 GM008353NIGMS NIH HHS T32 GM145304
6 · The paper itself

Abstract

Capsular polysaccharides (CPSs) play multiple roles in protecting bacteria from host and environmental factors, and many commensal bacteria can produce multiple capsule types. To better understand the roles of different CPSs in competitive intestinal colonization, we individually expressed the eight different capsules of the human gut symbiont Bacteroides thetaiotaomicron. Certain CPSs were most advantageous in vivo, and increased anti-CPS immunoglobulin A correlated with increased fitness of a strain expressing one particular capsule, CPS5, suggesting that it promotes avoidance of adaptive immunity. A strain with the ability to switch between multiple capsules was more competitive than those expressing any single capsule except CPS5. After antibiotic perturbation, only the wild-type, capsule-switching strain remained in the gut, shifting to prominent expression of CPS5 only in mice with intact adaptive immunity. These data suggest that different capsules equip mutualistic gut bacteria with the ability to thrive in various niches, including those influenced by immune responses and antibiotic perturbations.

Indexed as

Adaptive ImmunityAge FactorsAnimalsBacterial CapsulesBacteroides thetaiotaomicronFecesFemaleGastrointestinal MicrobiomeGenetic FitnessHumansImmunoglobulin AIntestinesMaleMiceMice, Inbred C57BLMicrobial InteractionsImmunoglobulin APolysaccharides, BacterialBacteroidescapsular polysaccharidedietIgAimmune responsemicrobiomemicrobiota

Identifiers

PMID28966055
PMCPMC5830307
OpenAlexW2756886713

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.